How GW Pharmaceuticals Hit a Home Run in Q1
Like many stocks, GW Pharmaceuticals (NASDAQ: GWPH) took a beating in the coronavirus-fueled market sell-off earlier this year. However, GW's shares bounced back and have largely recovered. That recovery should now pick up even more steam.
GW Pharmaceuticals announced its first-quarter results after the market closed on Monday. And those results were exactly what investors hoped for. Here's how GW hit a home run in Q1.
Image source: GW Pharmaceuticals.
Source Fool.com
